Richard Law CFA
Stock Analyst at Goldman Sachs
(1.93)
# 3,409
Out of 5,136 analysts
140
Total ratings
40.3%
Success rate
0.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Richard Law CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OLMA Olema Pharmaceuticals | Reiterated: Buy | $18 → $13 | $7.27 | +78.82% | 12 | Nov 11, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Hold | $28 → $29 | $30.65 | -5.38% | 10 | Nov 6, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $40 → $53 | $30.86 | +71.74% | 12 | Nov 4, 2026 | |
| BCAX Bicara Therapeutics | Downgraded: Sell | $20 → $8 | $10.18 | -21.41% | 6 | Oct 29, 2026 | |
| VKTX Viking Therapeutics | Rated: Hold | $38 → $34 | $28.66 | +18.63% | 4 | Oct 28, 2026 | |
| RCUS Arcus Biosciences | Reiterated: Buy | $42 | $18.67 | +124.96% | 6 | Oct 19, 2026 | |
| RCKT Rocket Pharmaceuticals | Upgraded: Hold | $3 → $4 | $2.45 | +63.27% | 8 | Oct 8, 2026 | |
| PTGX Protagonist Therapeutics | Reiterated: Buy | $186 | $136.26 | +36.50% | 8 | Aug 31, 2026 | |
| MLYS Mineralys Therapeutics | Reiterated: Buy | $42 → $40 | $15.52 | +157.73% | 13 | Aug 12, 2026 | |
| SLN Silence Therapeutics | Reiterated: Sell | $4 | $19.79 | -79.79% | 4 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $46 | $38.77 | +18.65% | 2 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $11 → $12 | $12.56 | -4.46% | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $29 → $33 | $27.39 | +20.50% | 3 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $31 | $9.33 | n/a | 6 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 | $25.15 | n/a | 4 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $62 → $63 | $45.15 | n/a | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $37 | $136.64 | n/a | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $11.17 | n/a | 7 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $10.50 | n/a | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $6.92 | n/a | 5 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $14 | $2.51 | n/a | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $10 | $3.00 | n/a | 2 | Feb 24, 2023 |
Olema Pharmaceuticals
Nov 11, 2026
Reiterated: Buy
Price Target: $18 → $13
Current: $7.27
Upside: +78.82%
Celldex Therapeutics
Nov 6, 2026
Reiterated: Hold
Price Target: $28 → $29
Current: $30.65
Upside: -5.38%
Viridian Therapeutics
Nov 4, 2026
Reiterated: Buy
Price Target: $40 → $53
Current: $30.86
Upside: +71.74%
Bicara Therapeutics
Oct 29, 2026
Downgraded: Sell
Price Target: $20 → $8
Current: $10.18
Upside: -21.41%
Viking Therapeutics
Oct 28, 2026
Rated: Hold
Price Target: $38 → $34
Current: $28.66
Upside: +18.63%
Arcus Biosciences
Oct 19, 2026
Reiterated: Buy
Price Target: $42
Current: $18.67
Upside: +124.96%
Rocket Pharmaceuticals
Oct 8, 2026
Upgraded: Hold
Price Target: $3 → $4
Current: $2.45
Upside: +63.27%
Protagonist Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $186
Current: $136.26
Upside: +36.50%
Mineralys Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $42 → $40
Current: $15.52
Upside: +157.73%
Silence Therapeutics
Jul 27, 2026
Reiterated: Sell
Price Target: $4
Current: $19.79
Upside: -79.79%
Jul 13, 2026
Reiterated: Buy
Price Target: $36 → $46
Current: $38.77
Upside: +18.65%
May 11, 2026
Reiterated: Sell
Price Target: $11 → $12
Current: $12.56
Upside: -4.46%
Feb 27, 2026
Reiterated: Hold
Price Target: $29 → $33
Current: $27.39
Upside: +20.50%
Aug 15, 2023
Reiterated: Hold
Price Target: $36 → $31
Current: $9.33
Upside: n/a
Aug 9, 2023
Reiterated: Hold
Price Target: $47
Current: $25.15
Upside: n/a
Aug 8, 2023
Reiterated: Hold
Price Target: $62 → $63
Current: $45.15
Upside: n/a
Aug 4, 2023
Reiterated: Hold
Price Target: $36 → $37
Current: $136.64
Upside: n/a
Jun 13, 2023
Reiterated: Buy
Price Target: $76
Current: $11.17
Upside: n/a
May 12, 2023
Reiterated: Hold
Price Target: $11
Current: $10.50
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $61
Current: $6.92
Upside: n/a
May 5, 2023
Reiterated: Hold
Price Target: $15 → $14
Current: $2.51
Upside: n/a
Feb 24, 2023
Upgraded: Hold
Price Target: $10
Current: $3.00
Upside: n/a